In the last 19 years, only 3.29 % trading sessions saw intraday gains higher than 5 % .
Aarti Inds - Aarti Industries Share Price
Aarti Inds - Aarti Indu...
Aarti Inds share price insights
Sales de-grew by 3.62%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
White Spinning Top was formed for Aarti Inds
Company has spent 3.31% of its operating revenues towards interest expenses and 6.34% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Aarti Industries Ltd. share price moved up by 0.57% from its previous close of Rs 714.40. Aarti Industries Ltd. stock last traded price is 718.45
Share Price Value Today/Current/Last 718.45 Previous Day 714.40
Key Metrics
PE Ratio (x) | 62.51 | ||||||||||
EPS - TTM (₹) | 11.49 | ||||||||||
MCap (₹ Cr.) | 26,044.10 | ||||||||||
Sectoral MCap Rank | 20 | ||||||||||
PB Ratio (x) | 4.90 | ||||||||||
Div Yield (%) | 0.14 | ||||||||||
Face Value (₹) | 5.00 | ||||||||||
Beta Beta
| 0.21 | ||||||||||
VWAP (₹) | 720.18 | ||||||||||
52W H/L (₹) |
Aarti Inds Share Price Returns
1 Day | 0.57% |
1 Week | 4.55% |
1 Month | 20.02% |
3 Months | 3.84% |
1 Year | 46.41% |
3 Years | -17.83% |
5 Years | 62.18% |
Aarti Inds News & Analysis
Aarti Inds Share Recommendations
Recent Recos
Current
Mean Recos by 18 Analysts
SellSellHoldBuyStrong
Buy
That's all for Aarti Inds recommendations. Check out other stock recos.
Analyst Trends
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 |
Buy | 5 | 5 | 6 | 6 |
Hold | 5 | 5 | 4 | 5 |
Sell | 4 | 4 | 4 | 3 |
Strong Sell | 3 | 3 | 3 | 3 |
# Analysts | 18 | 18 | 18 | 18 |
Aarti Inds Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Topline Contraction
Sales de-grew by 3.62%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 3.31% of its operating revenues towards interest expenses and 6.34% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Quarterly | Annual Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Total Income 1,773.00 1,740.00 1,454.02 1,414.00 1,656.00 Total Income Growth (%) 1.90 19.67 2.83 -14.61 -0.72 Total Expenses 1,588.00 1,569.00 1,314.24 1,302.00 1,488.00 Total Expenses Growth (%) 1.21 19.38 0.94 -12.50 1.84 EBIT 185.00 171.00 139.78 112.00 168.00 EBIT Growth (%) 8.19 22.34 24.80 -33.33 -18.79 Profit after Tax (PAT) 132.00 124.00 90.65 70.00 149.00 PAT Growth (%) 6.45 36.79 29.50 -53.02 9.13 EBIT Margin (%) 10.43 9.83 9.61 7.92 10.14 Net Profit Margin (%) 7.45 7.13 6.23 4.95 9.00 Basic EPS (₹) 3.64 3.42 2.50 1.93 4.10 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 9,615.55 8,580.90 7,850.68 7,641.68 6,332.50 Total Assets Growth (%) 12.06 9.30 2.74 20.67 8.10 Total Liabilities 4,325.05 3,660.12 3,333.99 4,126.54 3,259.11 Total Liabilities Growth (%) 18.17 9.78 -19.21 26.62 3.69 Total Equity 5,290.50 4,920.78 4,516.69 3,515.14 3,073.39 Total Equity Growth (%) 7.51 8.95 28.49 14.37 13.21 Current Ratio (x) 0.96 0.88 1.25 0.99 1.05 Total Debt to Equity (x) 0.60 0.58 0.57 0.71 0.61 Contingent Liabilities 0.00 652.82 1,008.90 439.02 568.36 All figures in Rs Cr, unless mentioned otherwise
Insights
Decrease in Cash from Investing
Company has used Rs 1309.62 cr for investing activities which is an YoY decrease of 1.52%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 1,203.59 1,309.80 518.65 872.71 1,102.06 Net Cash used in Investing Activities -1,309.62 -1,329.78 -1,169.43 -1,322.14 -1,124.06 Net Cash flow from Financing Activities 35.02 47.15 412.02 614.46 -534.91 Net Cash Flow -71.01 27.17 -238.76 165.03 -556.91 Closing Cash & Cash Equivalent 41.78 200.73 173.56 412.32 247.29 Closing Cash & Cash Equivalent Growth (%) -79.19 15.65 -57.91 66.74 -69.25 Total Debt/ CFO (x) 2.65 2.19 4.95 2.86 1.64 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 7.86 11.08 26.25 14.94 17.99 Return on Capital Employed (%) 8.60 13.44 25.93 14.32 18.13 Return on Assets (%) 4.32 6.35 15.10 6.85 8.46 Interest Coverage Ratio (x) 4.66 6.48 16.82 8.69 6.42 Asset Turnover Ratio (x) 0.70 0.81 0.79 58.96 66.10 Price to Earnings (x) 58.14 34.48 29.24 43.86 24.81 Price to Book (x) 4.57 3.82 7.68 6.55 4.46 EV/EBITDA (x) 27.65 19.69 21.54 25.48 15.14 EBITDA Margin (%) 15.44 16.46 28.27 21.79 23.55
Aarti Inds Peer Comparison
Aarti Inds Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of -20.76% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -20.76% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of -20.76% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -20.76% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
485.11
Amount Invested (in Cr.)
0.74%
% of AUM
0.00
% Change (MoM basis)
126.30
Amount Invested (in Cr.)
1.25%
% of AUM
0.00
% Change (MoM basis)
81.70
Amount Invested (in Cr.)
0.16%
% of AUM
0.00
% Change (MoM basis)
MF Ownership as on 31 May 2024
Aarti Inds F&O Quote
Futures
Options
- Expiry
Price
721.903.80 (0.53%)
Open Interest
1,20,96,000-47,000 (-0.39%)
Open High Low Prev Close Contracts Traded Turnover (₹ Lakhs) 718.80 730.05 708.95 718.10 3,415 24,656.73 Open Interest as of 04 Jul 2024
Corporate Actions
Aarti Inds Board Meeting/AGM
Aarti Inds Dividends
- Others
Meeting Date Announced on Purpose Details May 10, 2024 May 02, 2024 Board Meeting Audited Results & Final Dividend Feb 08, 2024 Jan 25, 2024 Board Meeting Quarterly Results Nov 04, 2023 Oct 27, 2023 Board Meeting Quarterly Results Aug 08, 2023 Jul 31, 2023 Board Meeting Quarterly Results Aug 04, 2023 Jun 28, 2023 AGM - Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 30% 1.5 Jul 28, 2023 May 08, 2023 Interim 20% 1.0 Feb 15, 2023 Feb 03, 2023 Final 30% 1.5 Sep 16, 2022 May 27, 2022 Interim 20% 1.0 Feb 15, 2022 Feb 07, 2022 Final 20% 1.0 - May 10, 2024 All Types Ex-Date Record Date Announced on Details Bonus Jun 22, 2021 Jun 23, 2021 May 18, 2021 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Sep 27, 2019 Sep 30, 2019 Aug 13, 2019 Bonus Ratio: 1 share(s) for every 1 shares held Splits Jan 13, 2006 Jan 20, 2006 Oct 31, 2005 Split: Old FV10.0| New FV:5.0 Bonus Feb 09, 2005 Feb 10, 2005 Dec 29, 2004 Bonus Ratio: 2 share(s) for every 1 shares held Bonus Oct 21, 1994 Nov 17, 1994 Jul 22, 1994 Bonus Ratio: 1 share(s) for every 1 shares held
About Aarti Inds
Aarti Industries Ltd., incorporated in the year 1984, is a Mid Cap company (having a market cap of Rs 26,044.10 Crore) operating in Pharmaceuticals sector. Aarti Industries Ltd. key Products/Revenue Segments include Speciality Chemicals and Other Operating Revenue for the year ending 31-Mar-2023. Show More
Executives
Auditors
- CV
Chandrakant V Gogri
Chairman EmeritusRVRajendra V Gogri
Chairman & Managing DirectorRCRashesh C Gogri
Vice Chairman & Mng.DirectorAKAjay Kumar Gupta
Executive DirectorShow More - Gokhale & SatheKirtane & Pandit LLP
Industry
Key Indices Listed on
Nifty Smallcap 100, Nifty 500, BSE 500, + 14 more
Address
Plot Nos. 801, 801/23,G.I.D.C. Estate,Valsad District, Gujarat - 396195
More Details
FAQs about Aarti Inds share
- 1. What's the Aarti Inds share price today?As on 04 Jul, 2024, 03:58 PM IST Aarti Inds share price was up by 0.57% basis the previous closing price of Rs 711. Aarti Inds share price was Rs 718.45. Return Performance of Aarti Inds Shares:
- 1 Week: Aarti Inds share price moved up by 4.55%
- 1 Month: Aarti Inds share price moved up by 20.02%
- 3 Month: Aarti Inds share price moved up by 3.84%
- 6 Month: Aarti Inds share price moved up by 11.49%
- 2. What is the CAGR of Aarti Inds?The CAGR of Aarti Inds is 9.05.
- 3. Who owns Aarti Inds?Following are the key changes to Aarti Inds shareholding:
- Promoter holding have gone down from 43.65 (30 Jun 2023) to 43.43 (31 Mar 2024)
- Domestic Institutional Investors holding has gone up from 14.83 (30 Jun 2023) to 17.12 (31 Mar 2024)
- Foreign Institutional Investors holding have gone down from 12.17 (30 Jun 2023) to 10.93 (31 Mar 2024)
- Other investor holding have gone down from 29.34 (30 Jun 2023) to 28.51 (31 Mar 2024)
- 4. How can I quickly analyze Aarti Inds stock?Key Metrics for Aarti Inds are:
- PE Ratio of Aarti Inds is 62.51
- Price/Sales ratio of Aarti Inds is 3.79
- Price to Book ratio of Aarti Inds is 4.90
- 5. What are the Aarti Inds quarterly results?On Consoldiated basis, Aarti Inds reported a total income and profit of Rs 1773.00 Cr and Rs 132.00 respectively for quarter ending 2024-03-31. Total Income and profit for the year ending 2024-03-31 was Rs 6380.00 Cr and Rs 416.00 Cr.
- 6. What are the returns for Aarti Inds share?Return Performance of Aarti Inds Shares:
- 1 Week: Aarti Inds share price moved up by 4.55%
- 1 Month: Aarti Inds share price moved up by 20.02%
- 3 Month: Aarti Inds share price moved up by 3.84%
- 6 Month: Aarti Inds share price moved up by 11.49%
- 7. What is the market cap of Aarti Inds?Within the Pharmaceuticals sector, Aarti Inds stock has a market cap rank of 20. Aarti Inds has a market cap of Rs 26,044.10 Cr.
- 8. What is the PE & PB ratio of Aarti Inds?The PE ratio of Aarti Inds stands at 62.25, while the PB ratio is 4.9.
- 9. Who are the peers for Aarti Inds in Pharmaceuticals sector?Within Pharmaceuticals sector Aarti Inds, J B Chemicals & Pharmaceuticals Ltd., Laurus Labs Ltd., Ajanta Pharma Ltd., Ipca Laboratories Ltd., Syngene International Ltd., Gland Pharma Ltd., Natco Pharma Ltd., Piramal Pharma Ltd., Suven Pharmaceuticals Ltd. and Alembic Pharmaceuticals Ltd. are usually compared together by investors for analysis.
- 10. Is Aarti Inds giving dividend?Aarti Industries Ltd. announced an equity dividend of 30% on a face value of 5.0 amounting to Rs 1.5 per share on 08 May 2023. The ex dividend date was 28 Jul 2023.
- 11. Should I buy, sell or hold Aarti Inds?As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 18 analysts for Aarti Inds stock is to Hold. Recommendation breakup is as follows
- 1 analyst is recommending Strong Buy
- 5 analysts are recommending to Buy
- 5 analysts are recommending to Hold
- 4 analysts are recommending to Sell
- 3 analysts are recommending Strong Sell
- 12. What is 52 week high/low of Aarti Inds share price?Aarti Inds share price saw a 52 week high of Rs 769.25 and 52 week low of Rs 438.00.
- 13. Who is the chairman of Aarti Inds?Chandrakant V Gogri is the Chairman Emeritus of Aarti Inds
Trending in Markets
Aarti Inds Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.